NIPBL
Nipped-B-like protein
Also known as: DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, NIPBL_HUMAN, Scc2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6KC79
- Gene
- NIPBL
- Ensembl
- ENSG00000164190
- Chromosome
- 5
- Canonical length
- 2804 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes the homolog of the Drosophila melanogaster Nipped-B gene product and fungal Scc2-type sister chromatid cohesion proteins. The Drosophila protein facilitates enhancer-promoter communication of remote enhancers and plays a role in developmental regulation. It is also homologous to a family of chromosomal adherins with broad roles in sister chromatid cohesion, chromosome condensation, and DNA repair. The human protein has a bipartite nuclear targeting sequence and a putative HEAT repeat. Condensins, cohesins and other complexes with chromosome-related functions also contain HEAT repeats. Mutations in this gene result in Cornelia de Lange syndrome, a disorder characterized by dysmorphic facial features, growth delay, limb reduction defects, and cognitive disability. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
2804 residues, UniProt reviewed canonical sequence.
>Q6KC79|NIPBL
1 MNGDMPHVPI TTLAGIASLT DLLNQLPLPS PLPATTTKSL LFNARIAEEV NCLLACRDDN
61 LVSQLVHSLN QVSTDHIELK DNLGSDDPEG DIPVLLQAVL ARSPNVFREK SMQNRYVQSG
121 MMMSQYKLSQ NSMHSSPASS NYQQTTISHS PSSRFVPPQT SSGNRFMPQQ NSPVPSPYAP
181 QSPAGYMPYS HPSSYTTHPQ MQQASVSSPI VAGGLRNIHD NKVSGPLSGN SANHHADNPR
241 HGSSEDYLHM VHRLSSDDGD SSTMRNAASF PLRSPQPVCS PAGSEGTPKG SRPPLILQSQ
301 SLPCSSPRDV PPDILLDSPE RKQKKQKKMK LGKDEKEQSE KAAMYDIISS PSKDSTKLTL
361 RLSRVRSSDM DQQEDMISGV ENSNVSENDI PFNVQYPGQT SKTPITPQDI NRPLNAAQCL
421 SQQEQTAFLP ANQVPVLQQN TSVAAKQPQT SVVQNQQQIS QQGPIYDEVE LDALAEIERI
481 ERESAIERER FSKEVQDKDK PLKKRKQDSY PQEAGGATGG NRPASQETGS TGNGSRPALM
541 VSIDLHQAGR VDSQASITQD SDSIKKPEEI KQCNDAPVSV LQEDIVGSLK STPENHPETP
601 KKKSDPELSK SEMKQSESRL AESKPNENRL VETKSSENKL ETKVETQTEE LKQNESRTTE
661 CKQNESTIVE PKQNENRLSD TKPNDNKQNN GRSETTKSRP ETPKQKGESR PETPKQKSDG
721 HPETPKQKGD GRPETPKQKG ESRPETPKQK NEGRPETPKH RHDNRRDSGK PSTEKKPEVS
781 KHKQDTKSDS PRLKSERAEA LKQRPDGRSV SESLRRDHDN KQKSDDRGES ERHRGDQSRV
841 RRPETLRSSS RNEHGIKSDS SKTDKLERKH RHESGDSRER PSSGEQKSRP DSPRVKQGDS
901 NKSRSDKLGF KSPTSKDDKR TEGNKSKVDT NKAHPDNKAE FPSYLLGGRS GALKNFVIPK
961 IKRDKDGNVT QETKKMEMKG EPKDKVEKIG LVEDLNKGAK PVVVLQKLSL DDVQKLIKDR
1021 EDKSRSSLKP IKNKPSKSNK GSIDQSVLKE LPPELLAEIE STMPLCERVK MNKRKRSTVN
1081 EKPKYAEISS DEDNDSDEAF ESSRKRHKKD DDKAWEYEER DRRSSGDHRR SGHSHEGRRS
1141 SGGGRYRNRS PSDSDMEDYS PPPSLSEVAR KMKKKEKQKK RKAYEPKLTP EEMMDSSTFK
1201 RFTASIENIL DNLEDMDFTA FGDDDEIPQE LLLGKHQLNE LGSESAKIKA MGIMDKLSTD
1261 KTVKVLNILE KNIQDGSKLS TLLNHNNDTE EEERLWRDLI MERVTKSADA CLTTINIMTS
1321 PNMPKAVYIE DVIERVIQYT KFHLQNTLYP QYDPVYRLDP HGGGLLSSKA KRAKCSTHKQ
1381 RVIVMLYNKV CDIVSSLSEL LEIQLLTDTT ILQVSSMGIT PFFVENVSEL QLCAIKLVTA
1441 VFSRYEKHRQ LILEEIFTSL ARLPTSKRSL RNFRLNSSDM DGEPMYIQMV TALVLQLIQC
1501 VVHLPSSEKD SNAEEDSNKK IDQDVVITNS YETAMRTAQN FLSIFLKKCG SKQGEEDYRP
1561 LFENFVQDLL STVNKPEWPA AELLLSLLGR LLVHQFSNKS TEMALRVASL DYLGTVAARL
1621 RKDAVTSKMD QGSIERILKQ VSGGEDEIQQ LQKALLDYLD ENTETDPSLV FSRKFYIAQW
1681 FRDTTLETEK AMKSQKDEES SEGTHHAKEI ETTGQIMHRA ENRKKFLRSI IKTTPSQFST
1741 LKMNSDTVDY DDACLIVRYL ASMRPFAQSF DIYLTQILRV LGENAIAVRT KAMKCLSEVV
1801 AVDPSILARL DMQRGVHGRL MDNSTSVREA AVELLGRFVL CRPQLAEQYY DMLIERILDT
1861 GISVRKRVIK ILRDICIEQP TFPKITEMCV KMIRRVNDEE GIKKLVNETF QKLWFTPTPH
1921 NDKEAMTRKI LNITDVVAAC RDTGYDWFEQ LLQNLLKSEE DSSYKPVKKA CTQLVDNLVE
1981 HILKYEESLA DSDNKGVNSG RLVACITTLF LFSKIRPQLM VKHAMTMQPY LTTKCSTQND
2041 FMVICNVAKI LELVVPLMEH PSETFLATIE EDLMKLIIKY GMTVVQHCVS CLGAVVNKVT
2101 QNFKFVWACF NRYYGAISKL KSQHQEDPNN TSLLTNKPAL LRSLFTVGAL CRHFDFDLED
2161 FKGNSKVNIK DKVLELLMYF TKHSDEEVQT KAIIGLGFAF IQHPSLMFEQ EVKNLYNNIL
2221 SDKNSSVNLK IQVLKNLQTY LQEEDTRMQQ ADRDWKKVAK QEDLKEMGDV SSGMSSSIMQ
2281 LYLKQVLEAF FHTQSSVRHF ALNVIALTLN QGLIHPVQCV PYLIAMGTDP EPAMRNKADQ
2341 QLVEIDKKYA GFIHMKAVAG MKMSYQVQQA INTCLKDPVR GFRQDESSSA LCSHLYSMIR
2401 GNRQHRRAFL ISLLNLFDDT AKTDVTMLLY IADNLACFPY QTQEEPLFIM HHIDITLSVS
2461 GSNLLQSFKE SMVKDKRKER KSSPSKENES SDSEEEVSRP RKSRKRVDSD SDSDSEDDIN
2521 SVMKCLPENS APLIEFANVS QGILLLLMLK QHLKNLCGFS DSKIQKYSPS ESAKVYDKAI
2581 NRKTGVHFHP KQTLDFLRSD MANSKITEEV KRSIVKQYLD FKLLMEHLDP DEEEEEGEVS
2641 ASTNARNKAI TSLLGGGSPK NNTAAETEDD ESDGEDRGGG TSGSLRRSKR NSDSTELAAQ
2701 MNESVDVMDV IAICCPKYKD RPQIARVVQK TSSGFSVQWM AGSYSGSWTE AKRRDGRKLV
2761 PWVDTIKESD IIYKKIALTS ANKLTNKVVQ TLRSLYAAKD GTSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NIPBL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- thymus: 28 nTPM
- bone marrow: 24 nTPM
- retina: 21 nTPM
- parathyroid gland: 18 nTPM
- thyroid gland: 16 nTPM
- tonsil: 16 nTPM
Single-cell type
- neutrophils: 1,264 nCPM
- neutrophil progenitors: 701 nCPM
- microglia: 571 nCPM
- pituicytes/fscs: 478 nCPM
- thyrotrophs: 455 nCPM
- sertoli cells: 447 nCPM
Immune cell
- basophil: 11 nTPM
- neutrophil: 7.8 nTPM
- eosinophil: 4.3 nTPM
- plasmacytoid DC: 3.4 nTPM
- naive CD8 T-cell: 3.3 nTPM
- non-classical monocyte: 3.3 nTPM
Brain region
- cerebellum: 38 nTPM
- white matter: 35 nTPM
- basal ganglia: 30 nTPM
- medulla oblongata: 30 nTPM
- choroid plexus: 30 nTPM
- pons: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NIPBL.
Disease | AllUniProt
Conditions NIPBL is implicated in, by any mechanism.
- Cornelia de Lange syndrome 1 (CDLS1) MIM:122470
Disease | GeneticClinVar
592 pathogenic / likely-pathogenic of 2,388 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.03
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.57
- DepMap mean gene effect
- -0.57
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- cellular response to X-ray
- chromatin looping
- chromatin remodeling
- cognition
- developmental growth
- digestive tract development
- DNA damage response
- ear morphogenesis
- embryonic digestive tract morphogenesis
- embryonic forelimb morphogenesis
- embryonic viscerocranium morphogenesis
- establishment of mitotic sister chromatid cohesion
- establishment of protein localization to chromatin
- eye morphogenesis
- face morphogenesis
- fat cell differentiation
- forelimb morphogenesis
- gallbladder development
- heart morphogenesis
- intracellular protein localization
- maintenance of mitotic sister chromatid cohesion
- metanephros development
- mitotic sister chromatid cohesion
- mitotic sister chromatid segregation
- negative regulation of transcription by RNA polymerase II
- outflow tract morphogenesis
- positive regulation of multicellular organism growth
- positive regulation of neuron migration
- positive regulation of ossification
- positive regulation of transcription by RNA polymerase II
- regulation of developmental growth
- regulation of embryonic development
- regulation of hair cycle
- replication-born double-strand break repair via sister chromatid exchange
- sensory perception of sound
- somatic stem cell population maintenance
- uterus morphogenesis
- external genitalia morphogenesis
Molecular functions
- chromatin binding
- chromo shadow domain binding
- cohesin loader activity
- histone deacetylase binding
- mediator complex binding
- promoter-specific chromatin binding
- transcription corepressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-like helical
- Armadillo-type fold
- Sister chromatid cohesion C-terminal domain
- HEAT repeat associated with sister chromatid cohesion protein
- Scc2/Nipped-B family
- HEAT repeat associated with sister chromatid cohesion
- Sister chromatid cohesion C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NIPBL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NIPBL as an antibody target. Whether an autoantibody or antibody against NIPBL could matter depends on whether native NIPBL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NIPBL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NIPBL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...